ID   JAK3_HUMAN              Reviewed;        1124 AA.
AC   P52333; Q13259; Q13260; Q13611; Q99699; Q9Y6S2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   02-NOV-2010, entry version 123.
DE   RecName: Full=Tyrosine-protein kinase JAK3;
DE            EC=2.7.10.2;
DE   AltName: Full=Janus kinase 3;
DE            Short=JAK-3;
DE   AltName: Full=Leukocyte janus kinase;
DE            Short=L-JAK;
GN   Name=JAK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=94294384; PubMed=8022790; DOI=10.1073/pnas.91.14.6374;
RA   Kawamura M., McVicar D.W., Johnston J.A., Blake T.B., Chen Y.-Q.,
RA   Lal B.K., Lloyd A.R., Kelvin D.J., Staples J.E., Ortaldo J.R.,
RA   O'Shea J.J.;
RT   "Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase
RT   expressed in natural killer cells and activated leukocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6374-6378(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING
RP   (ISOFORM 2).
RX   MEDLINE=96027605; PubMed=7559633; DOI=10.1074/jbc.270.42.25028;
RA   Lai K.S., Jin Y., Graham D.K., Witthuhn B.A., Ihle J.N., Liu E.T.;
RT   "A kinase-deficient splice variant of the human JAK3 is expressed in
RT   hematopoietic and epithelial cancer cells.";
RL   J. Biol. Chem. 270:25028-25036(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=97079659; PubMed=8921370; DOI=10.1006/geno.1996.0520;
RA   Riedy M.C., Dutra A.S., Blake T.B., Modi W., Lal B.K., Davis J.,
RA   Bosse A., O'Shea J.J., Johnston J.A.;
RT   "Genomic sequence, organization, and chromosomal localization of human
RT   JAK3.";
RL   Genomics 37:57-61(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-132 AND ILE-722.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-191.
RX   MEDLINE=96278845; PubMed=8662778; DOI=10.1074/jbc.271.24.13976;
RA   Verbsky J.W., Bach E.A., Fang Y.F., Yang L., Randolph D.A.,
RA   Fields L.E.;
RT   "Expression of Janus kinase 3 in human endothelial and other non-
RT   lymphoid and non-myeloid cells.";
RL   J. Biol. Chem. 271:13976-13980(1996).
RN   [7]
RP   INTERACTION WITH STAM2.
RC   TISSUE=Fetal brain;
RX   MEDLINE=20359291; PubMed=10899310; DOI=10.1016/S0014-5793(00)01760-9;
RA   Endo K., Takeshita T., Kasai H., Sasaki Y., Tanaka N., Asao H.,
RA   Kikuchi K., Yamada M., Chenb M., O'Shea J.J., Sugamura K.;
RT   "STAM2, a new member of the STAM family, binding to the Janus
RT   kinases.";
RL   FEBS Lett. 477:55-61(2000).
RN   [8]
RP   INTERACTION WITH SHB.
RX   PubMed=12200137; DOI=10.1016/S0006-291X(02)02016-8;
RA   Lindholm C.K.;
RT   "IL-2 receptor signaling through the Shb adapter protein in T and NK
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 296:929-936(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-785, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783 AND TYR-785, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 814-1103 IN COMPLEX WITH
RP   STAUROSPORINE ANALOG AFN941, AND PHOSPHORYLATION AT TYR-980 AND
RP   TYR-981.
RX   PubMed=15831699; DOI=10.1182/blood-2005-02-0707;
RA   Boggon T.J., Li Y., Manley P.W., Eck M.J.;
RT   "Crystal structure of the Jak3 kinase domain in complex with a
RT   staurosporine analog.";
RL   Blood 106:996-1002(2005).
RN   [12]
RP   VARIANT T(-)B(+)NK(-) SCID CYS-100.
RX   MEDLINE=95388142; PubMed=7659163; DOI=10.1038/377065a0;
RA   Macchi P., Villa A., Giliani S., Sacco M.G., Frattini A., Porta F.,
RA   Ugazio A.G., Johnston J.A., Candotti F., O'Shea J.J., Vezzoni P.,
RA   Notarangelo L.D.;
RT   "Mutations of Jak-3 gene in patients with autosomal severe combined
RT   immune deficiency (SCID).";
RL   Nature 377:65-68(1995).
RN   [13]
RP   VARIANTS T(-)B(+)NK(-) SCID GLY-481; 586-LEU--MET-592 DEL AND ARG-759.
RX   MEDLINE=98022793; PubMed=9354668;
RA   Candotti F., Oakes S.A., Johnston J.A., Giliani S., Schumacher R.F.,
RA   Mella P., Fiorini M., Ugazio A.G., Badolato R., Notarangelo L.D.,
RA   Bozzi F., Macchi P., Strina D., Vezzoni P., Blaese R.M., O'Shea J.J.,
RA   Villa A.;
RT   "Structural and functional basis for JAK3-deficient severe combined
RT   immunodeficiency.";
RL   Blood 90:3996-4003(1997).
RN   [14]
RP   VARIANT T(-)B(+)NK(-) SCID TRP-582.
RX   MEDLINE=98423994; PubMed=9753072;
RA   Bozzi F., Lefranc G., Villa A., Badolato R., Schumacher R.F.,
RA   Khalil G., Loiselet J., Bresciani S., O'Shea J.J., Vezzoni P.,
RA   Notarangelo L.D., Candotti F.;
RT   "Molecular and biochemical characterization of JAK3 deficiency in a
RT   patient with severe combined immunodeficiency over 20 years after bone
RT   marrow transplantation: implications for treatment.";
RL   Br. J. Haematol. 102:1363-1366(1998).
RN   [15]
RP   VARIANTS T(-)B(+)NK(-) SCID ARG-151 AND SER-910, AND VARIANT ILE-722.
RX   MEDLINE=20435064; PubMed=10982185; DOI=10.1007/s004390051012;
RA   Schumacher R.F., Mella P., Badolato R., Fiorini M., Savoldi G.,
RA   Giliani S., Villa A., Candotti F., Tampalini A., O'Shea J.J.,
RA   Notarangelo L.D.;
RT   "Complete genomic organization of the human JAK3 gene and mutation
RT   analysis in severe combined immunodeficiency by single-strand
RT   conformation polymorphism.";
RL   Hum. Genet. 106:73-79(2000).
RN   [16]
RP   VARIANTS T(-)B(+)NK(-) SCID ALA-58 DEL; GLU-169 AND SER-589, AND
RP   VARIANT ILE-722.
RX   PubMed=14615376; DOI=10.1182/blood-2003-06-2104;
RA   Roberts J.L., Lengi A., Brown S.M., Chen M., Zhou Y.-J., O'Shea J.J.,
RA   Buckley R.H.;
RT   "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and
RT   molecular analyses of 10 patients and outcomes of stem cell
RT   transplantation.";
RL   Blood 103:2009-2018(2004).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-12; HIS-40; THR-132; ARG-151;
RP   VAL-521; PRO-527; PHE-688 AND ILE-722.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine kinase of the non-receptor type, involved in
CC       the interleukin-2 and interleukin-4 signaling pathway.
CC       Phosphorylates STAT6, IRS1, IRS2 and PI3K.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with STAM2 and MYO18A (By similarity).
CC       Interacts with SHB.
CC   -!- INTERACTION:
CC       Q07666:KHDRBS1; NbExp=1; IntAct=EBI-518246, EBI-1364;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system; Peripheral membrane
CC       protein (By similarity). Note=Wholly intracellular, possibly
CC       membrane associated (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2; Synonyms=JAK3S, Spleen-JAK3;
CC         IsoId=P52333-1; Sequence=Displayed;
CC       Name=1; Synonyms=JAK3B, Breast-JAK3;
CC         IsoId=P52333-2; Sequence=VSP_004989;
CC         Note=May be inactive as it lacks some part of the kinase domain;
CC   -!- TISSUE SPECIFICITY: In NK cells and an NK-like cell line but not
CC       in resting T-cells or in other tissues. The S-form is more
CC       commonly seen in hematopoietic lines, whereas the B-form is
CC       detected in cells both of hematopoietic and epithelial origins.
CC   -!- DOMAIN: Possesses two phosphotransferase domains. The second one
CC       probably contains the catalytic domain (By similarity), while the
CC       presence of slight differences suggest a different role for domain
CC       1.
CC   -!- PTM: Tyrosine phosphorylated in response to IL-2 and IL-4.
CC   -!- DISEASE: Defects in JAK3 are a cause of severe combined
CC       immunodeficiency autosomal recessive T-cell-negative/B-cell-
CC       positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802]. A
CC       form of severe combined immunodeficiency (SCID), a genetically and
CC       clinically heterogeneous group of rare congenital disorders
CC       characterized by impairment of both humoral and cell-mediated
CC       immunity, leukopenia, and low or absent antibody levels. Patients
CC       present in infancy recurrent, persistent infections by
CC       opportunistic organisms. The common characteristic of all types of
CC       SCID is absence of T-cell-mediated cellular immunity due to a
CC       defect in T-cell development.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily.
CC   -!- SIMILARITY: Contains 1 FERM domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50227.1; Type=Miscellaneous discrepancy; Note=Wrong choice of CDS. Was erroneously described as an isoform JAK3M while it is a fragmentary mRNA of INSL3;
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JAK3ID41032ch19p13.html";
CC   -!- WEB RESOURCE: Name=JAK3base; Note=JAK3 mutation db;
CC       URL="http://bioinf.uta.fi/JAK3base/";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/JAK3";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/jak3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09607; AAA19626.1; -; mRNA.
DR   EMBL; U31601; AAC50226.1; -; mRNA.
DR   EMBL; U31602; AAC50227.1; ALT_SEQ; mRNA.
DR   EMBL; U70065; AAC50950.1; -; Genomic_DNA.
DR   EMBL; AF513860; AAM44860.1; -; Genomic_DNA.
DR   EMBL; AC007201; AAD22741.1; -; Genomic_DNA.
DR   EMBL; U57096; AAC50542.1; -; mRNA.
DR   IPI; IPI00002773; -.
DR   IPI; IPI00219418; -.
DR   PIR; A55747; A55747.
DR   RefSeq; NP_000206.2; -.
DR   UniGene; Hs.515247; -.
DR   PDB; 1YVJ; X-ray; 2.55 A; A=814-1103.
DR   PDB; 3LXK; X-ray; 2.00 A; A=806-1124.
DR   PDB; 3LXL; X-ray; 1.74 A; A=806-1124.
DR   PDBsum; 1YVJ; -.
DR   PDBsum; 3LXK; -.
DR   PDBsum; 3LXL; -.
DR   ProteinModelPortal; P52333; -.
DR   SMR; P52333; 374-783.
DR   DIP; DIP-274N; -.
DR   IntAct; P52333; 4.
DR   MINT; MINT-1497014; -.
DR   STRING; P52333; -.
DR   PhosphoSite; P52333; -.
DR   PRIDE; P52333; -.
DR   Ensembl; ENST00000458235; ENSP00000391676; ENSG00000105639.
DR   GeneID; 3718; -.
DR   KEGG; hsa:3718; -.
DR   UCSC; uc002nhn.2; human.
DR   UCSC; uc002nho.2; human.
DR   CTD; 3718; -.
DR   GeneCards; GC19M017935; -.
DR   HGNC; HGNC:6193; JAK3.
DR   MIM; 600173; gene.
DR   MIM; 600802; phenotype.
DR   Orphanet; 35078; Severe combined immunodeficiency T- B+ due to JAK3 deficiency.
DR   PharmGKB; PA29990; -.
DR   HOVERGEN; HBG006195; -.
DR   InParanoid; P52333; -.
DR   OrthoDB; EOG93V2DS; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; il2_pi3kpathway; IL2 signaling events mediated by PI3K.
DR   Pathway_Interaction_DB; il2_stat5pathway; IL2 signaling events mediated by STAT5.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; il4_2pathway; IL4-mediated signaling events.
DR   NextBio; 14571; -.
DR   ArrayExpress; P52333; -.
DR   Bgee; P52333; -.
DR   CleanEx; HS_JAK3; -.
DR   Genevestigator; P52333; -.
DR   GermOnline; ENSG00000105639; Homo sapiens.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR020775; Tyr_kinase_non-rcpt_Jak3.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF282; Tyr_kinase_non-rcpt_Jak3; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 2.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR01826; JANUSKINASE3.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF56112; Kinase_like; 2.
DR   PROSITE; PS00660; FERM_1; FALSE_NEG.
DR   PROSITE; PS00661; FERM_2; FALSE_NEG.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Repeat; SCID; SH2 domain; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1   1124       Tyrosine-protein kinase JAK3.
FT                                /FTId=PRO_0000088115.
FT   DOMAIN       24    356       FERM.
FT   DOMAIN      375    475       SH2; atypical.
FT   DOMAIN      521    781       Protein kinase 1.
FT   DOMAIN      822   1111       Protein kinase 2.
FT   NP_BIND     828    836       ATP (By similarity).
FT   ACT_SITE    949    949       Proton acceptor (By similarity).
FT   BINDING     855    855       ATP (By similarity).
FT   MOD_RES       8      8       Phosphothreonine (By similarity).
FT   MOD_RES     783    783       Phosphoserine.
FT   MOD_RES     785    785       Phosphotyrosine.
FT   MOD_RES     980    980       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     981    981       Phosphotyrosine; by autocatalysis.
FT   MOD_RES    1027   1027       Phosphoserine (By similarity).
FT   MOD_RES    1031   1031       Phosphoserine (By similarity).
FT   VAR_SEQ    1071   1124       HELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT
FT                                AHPEGKHHSLSFS -> SAAGLASVSQSVDWAGVSGKPAGA
FT                                (in isoform 1).
FT                                /FTId=VSP_004989.
FT   VARIANT      12     12       P -> L (in dbSNP:rs56061056).
FT                                /FTId=VAR_041722.
FT   VARIANT      40     40       R -> H (in dbSNP:rs56384680).
FT                                /FTId=VAR_041723.
FT   VARIANT      58     58       Missing (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_019337.
FT   VARIANT     100    100       Y -> C (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_006284.
FT   VARIANT     132    132       P -> T (in dbSNP:rs3212723).
FT                                /FTId=VAR_019336.
FT   VARIANT     151    151       P -> R (in T(-)B(+)NK(-) SCID;
FT                                dbSNP:rs55778349).
FT                                /FTId=VAR_010492.
FT   VARIANT     169    169       D -> E (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_019338.
FT   VARIANT     481    481       E -> G (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_010493.
FT   VARIANT     521    521       L -> V (in dbSNP:rs55666418).
FT                                /FTId=VAR_041724.
FT   VARIANT     527    527       L -> P (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041725.
FT   VARIANT     582    582       R -> W (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_010494.
FT   VARIANT     586    592       Missing (in T(-)B(+)NK(-) SCID; lack of
FT                                phosphorylation in response to cytokine
FT                                stimulation).
FT                                /FTId=VAR_010495.
FT   VARIANT     589    589       G -> S (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_019339.
FT   VARIANT     688    688       I -> F (in dbSNP:rs35785705).
FT                                /FTId=VAR_041726.
FT   VARIANT     722    722       V -> I (in dbSNP:rs3213409).
FT                                /FTId=VAR_010496.
FT   VARIANT     759    759       C -> R (in T(-)B(+)NK(-) SCID;
FT                                constitutive phosphorylation).
FT                                /FTId=VAR_010497.
FT   VARIANT     910    910       L -> S (in T(-)B(+)NK(-) SCID).
FT                                /FTId=VAR_010498.
FT   CONFLICT     34     34       G -> A (in Ref. 1; AAA19626).
FT   CONFLICT     45     45       F -> S (in Ref. 3; AAC50950).
FT   CONFLICT    103    103       R -> RS (in Ref. 3; AAC50950).
FT   CONFLICT    147    147       Missing (in Ref. 6; AAC50542).
FT   CONFLICT    187    187       T -> A (in Ref. 6; AAC50542).
FT   CONFLICT    212    212       R -> A (in Ref. 1; AAA19626 and 3;
FT                                AAC50950).
FT   CONFLICT    222    222       R -> P (in Ref. 1; AAA19626 and 3;
FT                                AAC50950).
FT   CONFLICT    271    271       L -> F (in Ref. 3; AAC50950).
FT   CONFLICT    287    287       Missing (in Ref. 3; AAC50950).
FT   CONFLICT    610    610       M -> I (in Ref. 2; AAC50226).
FT   CONFLICT    845    846       GD -> AH (in Ref. 1; AAA19626).
FT   CONFLICT    895    897       RQS -> EPE (in Ref. 3; AAC50950).
FT   CONFLICT    896    897       QS -> PE (in Ref. 1; AAA19626).
FT   HELIX       819    821
FT   STRAND      822    830
FT   STRAND      835    841
FT   STRAND      843    847
FT   STRAND      851    856
FT   HELIX       864    877
FT   STRAND      886    889
FT   STRAND      893    896
FT   STRAND      899    902
FT   HELIX       910    916
FT   TURN        917    920
FT   HELIX       923    942
FT   HELIX       952    954
FT   STRAND      955    959
FT   STRAND      962    965
FT   STRAND      979    982
FT   HELIX       991    993
FT   HELIX       996   1001
FT   STRAND     1003   1005
FT   HELIX      1006   1021
FT   TURN       1022   1024
FT   HELIX      1030   1038
FT   STRAND     1041   1043
FT   HELIX      1046   1055
FT   HELIX      1068   1077
FT   HELIX      1082   1084
FT   HELIX      1088   1100
SQ   SEQUENCE   1124 AA;  125099 MW;  895D8563439B2B7C CRC64;
     MAPPSEETPL IPQRSCSLLS TEAGALHVLL PARGPGPPQR LSFSFGDHLA EDLCVQAAKA
     SGILPVYHSL FALATEDLSC WFPPSHIFSV EDASTQVLLY RIRFYFPNWF GLEKCHRFGL
     RKDLASAILD LPVLEHLFAQ HRSDLVSGRL PVGLSLKEQG ECLSLAVLDL ARMAREQAQR
     PGELLKTVSY KACLPPSLRD LIQGLSFVTR RRIRRTVRRA LRRVAACQAD RHSLMAKYIM
     DLERLDPAGA AETFHVGLPG ALGGHDGLGL LRVAGDGGIA WTQGEQEVLQ PFCDFPEIVD
     ISIKQAPRVG PAGEHRLVTV TRTDNQILEA EFPGLPEALS FVALVDGYFR LTTDSQHFFC
     KEVAPPRLLE EVAEQCHGPI TLDFAINKLK TGGSRPGSYV LRRSPQDFDS FLLTVCVQNP
     LGPDYKGCLI RRSPTGTFLL VGLSRPHSSL RELLATCWDG GLHVDGVAVT LTSCCIPRPK
     EKSNLIVVQR GHSPPTSSLV QPQSQYQLSQ MTFHKIPADS LEWHENLGHG SFTKIYRGCR
     HEVVDGEARK TEVLLKVMDA KHKNCMESFL EAASLMSQVS YRHLVLLHGV CMAGDSTMVQ
     EFVHLGAIDM YLRKRGHLVP ASWKLQVVKQ LAYALNYLED KGLPHGNVSA RKVLLAREGA
     DGSPPFIKLS DPGVSPAVLS LEMLTDRIPW VAPECLREAQ TLSLEADKWG FGATVWEVFS
     GVTMPISALD PAKKLQFYED RQQLPAPKWT ELALLIQQCM AYEPVQRPSF RAVIRDLNSL
     ISSDYELLSD PTPGALAPRD GLWNGAQLYA CQDPTIFEER HLKYISQLGK GNFGSVELCR
     YDPLGDNTGA LVAVKQLQHS GPDQQRDFQR EIQILKALHS DFIVKYRGVS YGPGRQSLRL
     VMEYLPSGCL RDFLQRHRAR LDASRLLLYS SQICKGMEYL GSRRCVHRDL AARNILVESE
     AHVKIADFGL AKLLPLDKDY YVVREPGQSP IFWYAPESLS DNIFSRQSDV WSFGVVLYEL
     FTYCDKSCSP SAEFLRMMGC ERDVPALCRL LELLEEGQRL PAPPACPAEV HELMKLCWAP
     SPQDRPSFSA LGPQLDMLWS GSRGCETHAF TAHPEGKHHS LSFS
//
